about
Mutation analysis of the DBC2 gene in sporadic and familial breast cancerLocalization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mappingNovel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder.Decreased gene expression activity as a result of a mutation in the calreticulin gene promoter in a family case of schizoaffective disorder.An exceptionally long CA-repeat in the core promoter of SCGB2B2 links with the evolution of apes and Old World monkeys.Exceptionally long 5' UTR short tandem repeats specifically linked to primates.Polymorphic core promoter GA-repeats alter gene expression of the early embryonic developmental genes.A primate-specific functional GTTT-repeat in the core promoter of CYTH4 is linked to bipolar disorder in human.Biased homozygous haplotypes across the human caveolin 1 upstream purine complex in Parkinson's disease.Haplotypes across the human caveolin 1 gene upstream purine complex significantly alter gene expression: implication in neurodegenerative disorders.Support for down-tuning of the calreticulin gene in the process of human evolution.Evolutionary trend of exceptionally long human core promoter short tandem repeats.A mutation in the calreticulin gene promoter in a family case of schizoaffective disorder leads to its aberrant transcriptional activation.A novel polymorphic purine complex at the 1.5 kb upstream region of the human caveolin-1 gene and risk of Alzheimer's disease; extra-short alleles and accumulated allele homozygosity.Core promoter STRs: novel mechanism for inter-individual variation in gene expression in humans.Association between the DRD2 A1 allele and opium addiction in the Iranian population.Novel extreme homozygote haplotypes at the human caveolin 1 gene upstream purine complex in sporadic Alzheimer's disease.Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder.BEND3 is involved in the human-specific repression of calreticulin: Implication for the evolution of higher brain functions in human.Dominant and Protective Role of the CYTH4 Primate-Specific GTTT-Repeat Longer Alleles Against Neurodegeneration.Core promoter short tandem repeats as evolutionary switch codes for primate speciation.A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia.Skewing of the genetic architecture at the ZMYM3 human-specific 5' UTR short tandem repeat in schizophrenia.Gender dimorphism in the DAT1 -67 T-allele homozygosity and predisposition to bipolar disorder.Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele.The human caveolin 1 gene upstream purine complex and neurodegeneration--a common signature.Genome-wide identification of human- and primate-specific core promoter short tandem repeats.RIT2 Polymorphisms: Is There a Differential Association?Aberrant expression of Activating Transcription Factor 6 (ATF6) in major psychiatric disorders.Association between polymorphisms in Interleukin-16 gene and risk of late-onset Alzheimer's disease.A genetic variant in CAMKK2 gene is possibly associated with increased risk of bipolar disorder.No association between the DAT1 10-repeat allele and ADHD in the Iranian population.Exceptional human core promoter nucleotide compositions.Link between short tandem repeats and translation initiation site selectionExceptional expansion and conservation of a CT-repeat complex in the core promoter ofPAXBP1in primatesReversion of the human calreticulin gene promoter to the ancestral type as a result of a novel psychosis-associated mutation
P50
Q28237756-5F4D68F1-C67A-481B-A962-3EF1F4E6D3F9Q34388583-BC4BAFC6-7718-4AF0-8ED9-E9AA63B7B472Q35003553-6D485766-F9A3-48D4-9324-603EB303C32CQ36910064-FE9971F0-5581-485A-AF0B-48A74929B8C7Q38830250-F32E5D1D-3B94-4327-9544-A5DD9155F10FQ39001542-821F39EF-C5B5-42A2-8F5C-58C8D8A31EBFQ39093478-727D7E24-F50F-438B-924A-0D3F5392AA55Q39125851-5B6A4915-E93A-4637-AA0F-E815C159E9ABQ39156780-47888508-3F6A-4C6D-A709-252998557DF6Q39338260-5C56D731-54AE-4EE5-B048-6DF4501B099DQ39514079-87E1FCFA-EF80-48B6-8ADD-C6EA154CB66BQ39586148-38BCF31E-700E-4B22-BD75-4F6DF20913C2Q42441907-BA73D9AD-16B0-4817-AD92-95F8C489CEB8Q42659466-0C8D156A-35E3-4217-BEF8-9E8AA4609637Q44587472-D3A7F039-31C2-49D7-B765-337F3C3EDFA7Q45259968-E92AB1D2-A6DF-4398-A16D-9EB653944BBBQ45993191-248424D1-1369-4774-8F65-10A7A7011B83Q46379426-3E199F2C-E9B1-460D-8E6A-A2EA28E66369Q46651955-5DB0D344-F1FB-4B51-A52C-77CCF0954AFBQ46751303-C361DA44-248F-4900-AB61-AEC0FFD97C1EQ46855818-F85DFE12-B155-4926-A2A4-DB8C9730FA2EQ46971677-1488B9DF-E4B5-471C-87AB-D817D2334516Q47559916-5CA6A640-F876-4333-BED0-10ECA833B9FCQ48265977-3A38E9BA-ECB0-43C9-B288-211E9BD3CEB7Q48494116-D20B1FB1-95D9-47B0-8B0F-C1F6922CFDFCQ49157114-E0DEE0A5-0BC7-4BBF-883F-97A55BC8FCB5Q50216225-6975E08B-12A7-47DF-8F17-749E0E4EE2FEQ50227781-D381C784-52DC-45B9-888D-4353592FBB06Q50758498-EEB0410A-4FE0-421E-A21A-EE646A85182AQ50786686-B63799C9-CA9C-4A6E-A7B5-E21B0D07F87BQ50792441-DB0B5B82-CD7B-4811-A80D-DE74573E7675Q50974368-BF24FCFB-E3CF-442D-A443-78D82E05DA28Q53079930-2F1F8AFA-CFD8-493C-9E7A-C6ED00CE913AQ58103275-D5FB6596-62D6-4FEE-B15B-224D9D80DB49Q61249191-ADC9177E-FF7C-4520-9894-8628D68A7786Q61249199-728EE23C-7EBB-4DB4-BAC3-F25A36F1C282
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mina Ohadi
@ast
Mina Ohadi
@en
Mina Ohadi
@es
Mina Ohadi
@nl
Mina Ohadi
@sl
type
label
Mina Ohadi
@ast
Mina Ohadi
@en
Mina Ohadi
@es
Mina Ohadi
@nl
Mina Ohadi
@sl
prefLabel
Mina Ohadi
@ast
Mina Ohadi
@en
Mina Ohadi
@es
Mina Ohadi
@nl
Mina Ohadi
@sl
P106
P1153
8343649800
P21
P31
P496
0000-0003-1967-0576